Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q1 2027 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2027 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2027 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q1 2028 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q2 2028 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q3 2028 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q4 2028 | 1 | -$0.12 | -$0.12 | -$0.12 |
Medicinova Inc last posted its earnings results on Friday, May 15th, 2026. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.06 by $0.01. The company had revenue of 186.98 K for the quarter and had revenue of 409.66 K for the year. Medicinova Inc has generated $0 earnings per share over the last year ($-0.24 diluted earnings per share) and currently has a price-to-earnings ratio of -5.55. Medicinova Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2026 | Q1 2026 | N/A | -$0.05 | N/A | $186.98 K | $186.98 K |
| 03/10/2026 | Q4 2025 | N/A | -$0.05 | N/A | $151.74 K | $151.74 K |
| 11/12/2025 | Q3 2025 | -$0.08 | -$0.06 | 0.02 | $123.32 K | $123.32 K |
| 08/14/2025 | Q2 2025 | -$0.07 | -$0.07 | 0 | N/A | $134.60 K |
| 05/13/2025 | Q1 2025 | -$0.14 | -$0.06 | 0.08 | N/A | $0 |
| 02/19/2025 | Q4 2024 | -$0.06 | -$0.06 | 0 | N/A | $0 |
| 11/13/2024 | Q3 2024 | -$0.06 | -$0.06 | 0 | N/A | $0 |
| 08/08/2024 | Q2 2024 | -$0.06 | -$0.05 | 0.01 | N/A | $0 |
| 05/09/2024 | Q1 2024 | -$0.05 | -$0.06 | -0.01 | N/A | $0 |
| 02/15/2024 | Q4 2023 | -$0.08 | -$0.04 | 0.04 | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.08 | -$0.01 | 0.07 | N/A | $1.00 M |
| 08/09/2023 | Q2 2023 | -$0.07 | -$0.06 | 0.01 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.07 | -$0.06 | 0.01 | N/A | $0 |
| 03/28/2023 | Q4 2022 | N/A | -$0.06 | N/A | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$0.09 | -$0.07 | 0.02 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$0.08 | -$0.08 | -0 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.09 | -$0.07 | 0.02 | N/A | $0 |
| 02/16/2022 | Q4 2021 | -$0.09 | -$0.04 | 0.05 | N/A | $0 |
| 11/12/2021 | Q3 2021 | -$0.09 | -$0.07 | 0.02 | N/A | $37.50 K |
| 08/12/2021 | Q2 2021 | -$0.09 | -$0.09 | 0 | N/A | $0 |
In the previous quarter, Medicinova Inc (:MNOV) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.06 by $0.01.
The conference call for Medicinova Inc's latest earnings report can be listened to online.
The conference call transcript for Medicinova Inc's latest earnings report can be read online.
Medicinova Inc (:MNOV) has a recorded annual revenue of $409.66 K.
Medicinova Inc (:MNOV) has a recorded net income of $-11,997,957.Medicinova Inc has generated $-0.24 earnings per share over the last four quarters.
Medicinova Inc (:MNOV) has a price-to-earnings ratio of -5.55 and price/earnings-to-growth ratio is 15.33.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED